172 related articles for article (PubMed ID: 1331518)
1. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.
Tashiro M; Yokogoshi Y; Tobita K; Seto JT; Rott R; Kido H
J Virol; 1992 Dec; 66(12):7211-6. PubMed ID: 1331518
[TBL] [Abstract][Full Text] [Related]
2. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses.
Beppu Y; Imamura Y; Tashiro M; Towatari T; Ariga H; Kido H
J Biochem; 1997 Feb; 121(2):309-16. PubMed ID: 9089405
[TBL] [Abstract][Full Text] [Related]
3. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
Kido H; Niwa Y; Beppu Y; Towatari T
Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
[TBL] [Abstract][Full Text] [Related]
4. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of proteolytic activation of Sendai virus infection and the defensive compounds for infection.
Kido H; Beppu Y; Sakai K; Towatari T
Biol Chem; 1997; 378(3-4):255-63. PubMed ID: 9165079
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus.
Kido H; Sakai K; Kishino Y; Tashiro M
FEBS Lett; 1993 May; 322(2):115-9. PubMed ID: 8387030
[TBL] [Abstract][Full Text] [Related]
7. Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells.
Sakai K; Kohri T; Tashiro M; Kishino Y; Kido H
Eur Respir J; 1994 Apr; 7(4):686-92. PubMed ID: 8005249
[TBL] [Abstract][Full Text] [Related]
8. Electron immunohistochemical localization in rat bronchiolar epithelial cells of tryptase Clara, which determines the pneumotropism and pathogenicity of Sendai virus and influenza virus.
Sakai K; Kawaguchi Y; Kishino Y; Kido H
J Histochem Cytochem; 1993 Jan; 41(1):89-93. PubMed ID: 8380186
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein.
Kido H; Yokogoshi Y; Sakai K; Tashiro M; Kishino Y; Fukutomi A; Katunuma N
J Biol Chem; 1992 Jul; 267(19):13573-9. PubMed ID: 1618859
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice by a protease inhibitor, aprotinin, against lethal Sendai virus pneumonia.
Hayashi T; Hotta H; Itoh M; Homma M
J Gen Virol; 1991 Apr; 72 ( Pt 4)():979-82. PubMed ID: 1707950
[TBL] [Abstract][Full Text] [Related]
11. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.
Kido H; Murakami M; Oba K; Chen Y; Towatari T
Mol Cells; 1999 Jun; 9(3):235-44. PubMed ID: 10420980
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs.
Tashiro M; Beppu Y; Sakai K; Kido H
Arch Virol; 1996; 141(8):1571-7. PubMed ID: 8856034
[TBL] [Abstract][Full Text] [Related]
13. Evidence of proteolytic activation of Sendai virus in mouse lung.
Tashiro M; Homma M
Arch Virol; 1983; 77(2-4):127-37. PubMed ID: 6314932
[TBL] [Abstract][Full Text] [Related]
14. Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.
Mochizuki Y; Tashiro M; Homma M
J Virol; 1988 Aug; 62(8):3040-2. PubMed ID: 2839720
[TBL] [Abstract][Full Text] [Related]
15. Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice.
Tashiro M; Seto JT; Choosakul S; Yamakawa M; Klenk HD; Rott R
Virology; 1992 Apr; 187(2):413-22. PubMed ID: 1312267
[TBL] [Abstract][Full Text] [Related]
16. Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium.
Tashiro M; Yamakawa M; Tobita K; Klenk HD; Rott R; Seto JT
J Virol; 1990 Aug; 64(8):3627-34. PubMed ID: 2164589
[TBL] [Abstract][Full Text] [Related]
17. F0-containing noninfectious Sendai virus can initiate replication in mouse lungs but requires a relatively long incubation period.
Kiyotani K; Sakaguchi T; Fujii Y; Yoshida T
J Virol; 1993 Dec; 67(12):7618-22. PubMed ID: 7693976
[TBL] [Abstract][Full Text] [Related]
18. Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.
Tashiro M; Homma M
Infect Immun; 1983 Feb; 39(2):879-88. PubMed ID: 6299951
[TBL] [Abstract][Full Text] [Related]
19. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.
Itoh M; Ming TD; Hayashi T; Mochizuki Y; Homma M
J Virol; 1990 Nov; 64(11):5660-4. PubMed ID: 2170692
[TBL] [Abstract][Full Text] [Related]
20. Antibody against the carboxyl terminus of the F2 subunit of Sendai virus fusion glycoprotein inhibits proteolytic activation.
Tashiro M; Takeda M; Tanaka S; Nishimura N; Takenaka M; Kido H
Virology; 1993 Jun; 194(2):882-5. PubMed ID: 8389088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
